Using the EURONET-PHL-C1 strategy of limiting anthracycline and radiotherapy exposure using PET-CT as a response-assessment tool in children with classical Hodgkin lymphoma: Experience form Tata Medical Centre, Kolkata

• Sheetal Kulkarni Modi,
• Shekhar Krishnan,
• Jayanta Das,
• Rimpa Basu Achari,
• Indu Arun,
• Neeraj Arora,
• Arpita Bhattacharyya,
• Vaskar Saha,
• Anirban Das

Affiliations

Sheetal Kulkarni Modi

Department of Paediatric haematology/Oncology, Tata Medical Centre, Kolkata, India

Shekhar Krishnan

Department of Paediatric haematology/Oncology, Tata Medical Centre, Kolkata, India

Jayanta Das

Department of Nuclear Medicine, Tata Medical Centre, Kolkata, India

Rimpa Basu Achari

Department of Radiation Oncology, Tata Medical Centre, Kolkata, India

Indu Arun

Department of Histopathology, Tata Medical Centre, Kolkata, India

Neeraj Arora

Department of Haematopathology, Tata Medical Centre, Kolkata, India

Arpita Bhattacharyya

Department of Paediatric haematology/Oncology, Tata Medical Centre, Kolkata, India

Vaskar Saha

Department of Paediatric haematology/Oncology, Tata Medical Centre, Kolkata, India

Anirban Das

Department of Paediatric haematology/Oncology, Tata Medical Centre, Kolkata, India